Alkem Laboratories Limited (ALKEM) — Related Party Transaction

· NSE 🟡 Notable Neutral
📢 Key Event
Alkem Laboratories acquired 79,36,50,794 shares in Alkem Medtech at Rs. 13.86 per share for Rs. 11,00,00,00,005.
🔄 What Changed
Acquisition of 79,36,50,794 shares in Alkem Medtech at Rs. 13.86 per share for Rs. 11,00,00,00,005.
🔮 What's Next
Not applicable
💡 Investor Takeaway
This acquisition gives Alkem Laboratories control of Alkem Medtech, expanding its medical device presence in cardiovascular and orthopedic segments.

Alkem Laboratories announced it acquired 79,36,50,794 equity shares in Alkem Medtech Private Limited at Rs. 13.86 per share for a total consideration of Rs. 11,00,00,00,005, representing up to 55% of Occlutech Holding AG. The transaction was completed on 15 July 2026 and is disclosed under SEBI LODR Regulation 30.

📄 View Original Announcement (PDF)

About Alkem Laboratories Limited (ALKEM)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹65,593.36 Cr P/E: 27.7 ROE: 19.8% ROCE: 22.1%

View full ALKEM stock details →

📡 Get AI alerts when ALKEM files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track ALKEM — Free

📊 More ALKEM filings

See all ALKEM filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

📡 Get AI alerts when ALKEM files new disclosures

Track ALKEM filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track ALKEM — Free

Free account · 2 AI queries/day